Encompass Health Corp (EHC)

盈利方式

Revenue is a per-patient, per-stay payment collected almost entirely from third-party payors rather than from patients. Traditional Medicare, which pays inpatient rehabilitation facilities a prospective lump sum per discharge based on the patient's condition and case mix rather than on days or services used, is by far the largest source. Growth comes from filling existing beds, adding beds to current hospitals, and opening or acquiring new ones. Of $5,935.2 million of net operating revenues in fiscal 2025, $5,756 million came from inpatient services and roughly $179 million from other sources. The 2025 payor mix was 65.4% traditional Medicare, 16.4% Medicare Advantage, 10.7% managed care, 3.1% Medicaid, 0.7% other third-party payors, 0.5% workers' compensation, 0.3% paid directly by patients, and 2.9% other income.

Encompass Health is the largest operator in its niche, with 173 hospitals and 11,465 licensed beds at the end of 2025, and that scale is real: a national footprint spreads clinical protocols, staffing systems and the cost of regulatory compliance across far more discharges than a single-hospital competitor can. Barriers are reinforced by the rules themselves — an inpatient rehabilitation facility must meet strict Medicare admission criteria and quality-reporting obligations, and in many states a new hospital needs a certificate of need. Referral relationships with acute-care hospitals, several of them formalised as joint ventures with the referring system, are sticky for the same reason. But the advantage is narrow, not wide: the company's own filing lists competitive pressure among its risk factors, patients can be sent instead to skilled nursing facilities or home health, and the dominant payor sets the price unilaterally, so scale protects cost per discharge more than it protects the revenue line.

Nobody schedules a stroke around the business cycle. Demand comes from the incidence of disabling medical events — strokes, hip fractures, major surgeries, neurological disease — in an ageing population, and from acute-care hospitals wanting to discharge patients who still need intensive care. That makes volumes largely independent of recessions and consumer confidence: discharges rose in each of the last three years while revenue went from $4,801.2 million in 2023 to $5,373.2 million in 2024 and $5,935.2 million in 2025. The cyclical exposure that exists is political and fiscal rather than economic: the Medicare payment rate, the Medicare Advantage share of patients, and the wage cost of clinical staff.

主要风险

• Cuts, delays or suspension of reimbursement — The filing lists reductions or delays in, or suspension of, reimbursement by governmental or private payors as its first risk factor. Medicare sets the price administratively, so a rule change made in Washington reaches revenue without any commercial negotiation.
• Restrictive reading of what Medicare will pay for, and claim audits — Two separate risk factors cover restrictive interpretations of the regulations governing reimbursable claims and audits that may assert the company was overpaid. A further factor flags substantive and procedural deficiencies in the administrative appeals process for denied Medicare claims — money already earned can be clawed back and contested slowly.
• Shift in payor mix or patient acuity — The company states that changes in its payor mix or in the acuity of its patients could reduce revenues or profitability. Medicare Advantage plans and third-party payors and 'conveners' working to steer patients and cut payments to providers are called out as a distinct risk.
• Hiring and keeping clinical staff — Among operational risks the filing names the inability to attract and retain nurses, therapists and other healthcare professionals. Staffing is the input the business cannot substitute: beds without clinicians cannot take patients.
• Referral sources and joint-venture partners — Risk factors cover the inability to maintain or develop relationships with patient referral sources, and the possibility that acute-care hospitals participating in joint ventures with the company experience operational or financial difficulties of their own.
• Regulation, licensing and compliance — The company flags changes in healthcare rules at federal, state or local level, compliance with extensive and frequently changing laws applicable to healthcare providers, the inability to maintain proper licensing, quality-reporting requirements, and adverse outcomes of lawsuits and regulatory proceedings including qui tam suits.
• Expansion that does not integrate, and information-system incidents — The filing lists the inability to complete and integrate de novo developments, acquisitions, investments and joint ventures, and separately incidents affecting the operation, availability or security of the company's or its vendors' information systems, including patient information held in them.
• Debt and its covenants — Under financial risks the company states that its debt and the associated restrictive covenants could have negative consequences, alongside general conditions in the economy and capital markets, and warns it may be unable or unwilling to continue declaring and paying dividends.

主要客户占营收的65.4%

The real customer here is a payor, not a patient. Traditional Medicare alone accounted for 65.4% of 2025 revenues; Medicare Advantage plans added 16.4% and managed care 10.7%, with Medicaid at 3.1% and everything else in small single digits. The filing states plainly that revenues and receivables from Medicare are significant to its operations. Concentration of this kind is normal for an inpatient rehabilitation operator, but it means one administrative decision by a single payer moves the majority of the revenue line, and the company has no pricing power over it.